SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Total Non-current Assets

All assets not expected to be converted to cash within one year.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Total non-current assets of $5.02M in Q1 FY2026

Q1 FY2026 total non-current assets was $5.02M.

Context

  • Total non-current assets amounted to 1.9% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.02M-29.2% QoQ
Last fiscal yearDec 2025
$7.1M— YoY
Total Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Non-current Assets history

USD · from the balance sheet

Latest · FY2025
7.1M USD
Year-over-year change
—

Total Non-current Assets vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
  • Total non-current assets amounts to 1.9% of total assets for SGP, versus a peer median of 13.4%.
SGP Competitors
Total Non-current Assets for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$24.39B USD-3.1%+1.5%77.8%
BLCOBausch + Lomb CorporationJun 2026$10.94B USD-0.4%+7.0%78.9%
GKOSGlaukos CorporationJun 2026$404.74M USD-26.5%-12.8%44.0%
STAASTAAR Surgical CompanyApr 2026$138.72M USD+6.0%+11.9%30.8%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$38.71M USD+8.8%+67.3%13.4%
OCULOcular Therapeutix, Inc.Mar 2026$26.53M USD+45.6%+9.7%3.6%
RXSTRxSight, Inc.Mar 2026$24.77M USD+0.6%+16.0%8.1%
OCSOculis Holding AGMar 2026CHF 16.91M CHF+9.9%+8.4%6.9%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$5.02M USD——1.9%
SGHTSight Sciences, Inc.Mar 2026$3.19M USD+15.0%-8.9%2.9%
Peer median (excluding SGP) —+6.0%+8.4%13.4%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.